All In Biotech

Drug Trial Radar · NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

A Phase 2b/Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 942 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

942

Planned (sponsor's estimate)

Start

Sep 17, 2025

Primary completion

Nov 27, 2029

Study completion Jan 22, 2030

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Sep 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype. Participation to the study consists of 3 periods: * Screening period of up to 4 weeks * Randomized intervention period of approximately 48 weeks * Follow-up period: Approximately 8 weeks The study duration will be up to 60 weeks.

Conditions

  • Chronic Obstructive Pulmonary Disease

Interventions

  • LunsekimigDrug

    Pharmaceutical form: solution for injection in prefilled syringe. Route of administration: Subcutaneous injection

  • PlaceboDrug

    Pharmaceutical form: solution for injection. Route of administration: Subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized rate of moderate-to-severe chronic obstructive pulmonary disease (COPD) exacerbationsTime frame: From Baseline up to 48 weeks

Locations

314 sites in 26 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham- Site Number : 8400003

    Birmingham, Alabama · Recruiting

  • Pulmonary Associates - Mobile- Site Number : 8400151

    Mobile, Alabama · Recruiting

  • Tucson Clinical Research Institute- Site Number : 8400006

    Tucson, Arizona · Recruiting

  • Ark Clinical Research- Site Number : 8400113

    Long Beach, California · Recruiting

  • Inglewood Clinical- Site Number : 8400074

    Los Angeles, California · Recruiting

  • Alliance Clinical - West Hills- Site Number : 8400067

    Los Angeles, California · Recruiting

  • California Medical Research Associates - Northridge- Site Number : 8400089

    Northridge, California · Recruiting

  • Acclaim Clinical Research- Site Number : 8400068

    San Diego, California · Completed

  • Alpine Clinical Research Center - Boulder - 47th Street- Site Number : 8400005

    Boulder, Colorado · Recruiting

  • Critical Care Pulmonary & Sleep Associates- Site Number : 8400081

    Lakewood, Colorado · Recruiting

  • Howard University Hospital- Site Number : 8400080

    Washington D.C., District of Columbia · Recruiting

  • Meris Clinical Research- Site Number : 8400153

    Brandon, Florida · Recruiting

  • Hillcrest Medical Research- Site Number : 8400082

    DeLand, Florida · Recruiting

  • Finlay Medical Research - Greenacres- Site Number : 8400107

    Greenacres City, Florida · Recruiting

  • Direct Helpers Research Center- Site Number : 8400057

    Hialeah, Florida · Recruiting

  • University of Florida - Jacksonville- Site Number : 8400126

    Jacksonville, Florida · Recruiting

  • Salud Clinical Services- Site Number : 8400109

    Lehigh Acres, Florida · Recruiting

  • Pulmonary Specialists of the Palm Beaches- Site Number : 8400017

    Loxahatchee Groves, Florida · Recruiting

  • Elite Clinical Research - Miami- Site Number : 8400167

    Miami, Florida · Recruiting

  • DL Research Solutions- Site Number : 8400140

    Miami, Florida · Recruiting

  • Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027

    Miami, Florida · Recruiting

  • Professional Research Center- Site Number : 8400046

    Miami, Florida · Recruiting

  • Research Institute of South Florida- Site Number : 8400028

    Miami, Florida · Recruiting

  • Innovations Biotech- Site Number : 8400019

    Miami, Florida · Recruiting

  • Heuer M.D. Research- Site Number : 8400018

    Orlando, Florida · Recruiting

  • Florida Institute for Clinical Research- Site Number : 8400001

    Orlando, Florida · Recruiting

  • Avanza Medical Research Center- Site Number : 8400015

    Pensacola, Florida · Recruiting

  • Hull and Hull Medical Specialists- Site Number : 8400002

    Plantation, Florida · Recruiting

  • Windom Allergy, Asthma and Sinus Specialists- Site Number : 8400041

    Sarasota, Florida · Recruiting

  • Stat Care Pulmonary and Sleep- Site Number : 8400138

    St. Petersburg, Florida · Recruiting

  • Better Life Clinical Research- Site Number : 8400152

    Tampa, Florida · Recruiting

  • Vicis Clinical Research- Site Number : 8400158

    Tampa, Florida · Recruiting

  • Appalachian Clinical Research- Site Number : 8400060

    Adairsville, Georgia · Recruiting

  • Christie Clinic in Champaign on University- Site Number : 8400023

    Champaign, Illinois · Recruiting

  • Sneeze Wheeze & Itch Associates- Site Number : 8400020

    Normal, Illinois · Recruiting

  • Peoria Pulmonary Associates Ltd- Site Number : 8400095

    Peoria, Illinois · Recruiting

  • Asha Clinical Research - Munster- Site Number : 8400115

    Hammond, Indiana · Recruiting

  • Ochsner LSU Health Shreveport - Academic Medical Center- Site Number : 8400083

    Shreveport, Louisiana · Recruiting

  • Care Access - Shreveport - Youree Drive- Site Number : 8400007

    Shreveport, Louisiana · Recruiting

  • Johns Hopkins Bayview Medical Center- Site Number : 8400076

    Baltimore, Maryland · Recruiting

Showing 40 of 314 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.